We treat patients with a wide variety of diseases including hepato-biliary-pancreatic diseases such as chronic hepatitis, cirrhosis, hepatic cancer, and pancreatic cancer, as well as gastrointestinal diseases such as gastrointestinal cancer and inflammatory bowel disease.
We apply the latest treatments to patients with chronic hepatitis C or B with new antivirals, even playing a central role in the world. Patients with hepatic cancer are treated by radiofrequency ablation, transcatheter arterial embolization, and molecular target drugs on an interdisciplinary basis.
We strive to detect esophageal cancer, gastric cancer, and colorectal cancer at the early stage and perform proactively minimally-invasive treatment by endoscopic resection. We conduct clinical studies on the effects of chemotherapy with molecular-target drugs on patients with colorectal cancer and gastrointestinal stromal tumor and on the effects of chemoradiotherapy on patients with esophageal cancer and pancreatic cancer.
We are committed to providing holistic medical care services with respect for patients' opinions, based on high-quality medical techniques.